Evidence map›Paper›PMID 35899481›Full record

ArticleFuture microbiology2022

SARS-CoV-2 genomic epidemiology: data and sequencing infrastructure.

Georgi Merhi, Jad Koweyes, Tamara Salloum, Charbel Al Khoury, Siwar Haidar, Sima Tokajian

Abstract read
In one paragraph

Article in Future microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Enhancing the epidemiological surveillance of SARS-CoV-2 using Sanger sequencing to identify circulating variants and recombinants.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Georgi MerhiDepartment of Natural Sciences, School of Arts & Sciences, Lebanese American University, Byblos, Lebanon.ORCID 0000-0002-5558-4088
Jad KoweyesDepartment of Natural Sciences, School of Arts & Sciences, Lebanese American University, Byblos, Lebanon.ORCID 0000-0003-2010-6016
Tamara SalloumDepartment of Natural Sciences, School of Arts & Sciences, Lebanese American University, Byblos, Lebanon.ORCID 0000-0002-2689-4175
Charbel Al KhouryDepartment of Natural Sciences, School of Arts & Sciences, Lebanese American University, Byblos, Lebanon.ORCID 0000-0003-0977-1242
Siwar HaidarDepartment of Natural Sciences, School of Arts & Sciences, Lebanese American University, Byblos, Lebanon.ORCID 0000-0003-3882-4606
Sima TokajianDepartment of Natural Sciences, School of Arts & Sciences, Lebanese American University, Byblos, Lebanon.ORCID 0000-0002-3653-8940

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Genome, ViralGenomicsHumansSequence Analysislow- and middle-income countriesmolecular epidemiologynext-generation sequencing platformsSARS-CoV-2sequencing

Identifiers

PMID35899481
PMCPMC9332909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.